Sudden death in phenothiazine therapy. (A clinicopathologic study of 12 cases).
D000293:Adolescent; D000328:Adult; D000368:Aged; D001237:Asphyxia / Q000139:chemically induced; D001344:Autopsy; D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced / Q000473:pathology; D002746:Chlorpromazine / Q000009:adverse effects; D003645:Death, Sudden; D004357:Drug Synergism; D004562:Electrocardiography; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D006331:Heart Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D010546:Perphenazine / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects*; D011346:Prochlorperazine / Q000009:adverse effects; D012559:Schizophrenia / Q000188:drug therapy / Q000473:pathology; D013154:Spleen / Q000473:pathology; D013881:Thioridazine / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014273:Triflupromazine / Q000009:adverse effects
D010640:Phenothiazines; D014149:Tranquilizing Agents; D010546:Perphenazine; D013881:Thioridazine; D014273:Triflupromazine; D005476:Fluphenazine; D002746:Chlorpromazine; D011346:Prochlorperazine